Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $19.98 USD
Change Today -0.01 / -0.05%
Volume 130.3K
AMRI On Other Exchanges
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas E. D'Ambra Ph.D.

Co-Founder and Non-Executive Chairman,Albany Molecular Research Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 2 different organizations across 3 different industries.

See Board Relationships


Dr. Thomas E. D'Ambra, also known as Tom, Ph.D. co-founded Albany Molecular Research Inc. in 1991 and served as its Chief Executive Officer from 1991 to December 31, 2013. Dr. D'Ambra served as the President at Albany Molecular Research Inc. since February 2003. He served as the President of Molecular Research Inc., from 1991 to 1998. He co founded Coromed Inc., and served as its Vice President of Chemistry from 1989 to 1991. He served as Group Leader and Senior Research ...

Read Full Background

Corporate Headquarters*

26 Corporate Circle
Albany, New York 12203

United States

Phone: 518-512-2000
Fax: 518-512-2020

Board Members Memberships*

Co-Founder and Non-Executive Chairman


College of the Holy Cross
Massachusetts Institute of Technology

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$2,140,234
Total Calculated Compensation$2,210,234
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMRI:US $19.98 USD -0.01


Steven M. Klosk Chief Executive Officer, President and Director
Cambrex Corporation.
Masayo Tada Chief Executive Officer, President, Executive Director of Drug Development, Representative Director and Chairman of Risk Management Committee
Sumitomo Dainippon Pharma Co., Ltd.
Rudolf Hanko Ph.D.Chief Executive Officer and Member of Executive Committee
Siegfried Holding AG
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee
Emergent BioSolutions, Inc.
Dayanand Thandalam Sriram Managing Director and Director
GlaxoSmithKline Consumer Nigeria Plc
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALBANY MOLECULAR RESEARCH, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at